(Q28360503)

Revision as of 20:50, 8 August 2023 by Emijrpbot (talk | contribs) (‎Changed label, description and/or aliases in pt, pt-br, da, fr: BOT - Fixing descriptions (4 languages): da, fr, pt, pt-br)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

English

IGF status is altered by tamoxifen in patients with breast cancer.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11577172%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

IGF status is altered by tamoxifen in patients with breast cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11577172%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

0 references

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11577172%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

M J Campbell

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11577172%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

J Secker-Walker

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11577172%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

A Titcomb

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11577172%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

A J Leathem

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11577172%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

language of work or name

0 references

publication date

1 October 2001

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11577172%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Journal of Clinical Pathology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11577172%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

54

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11577172%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11577172%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

307-310

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11577172%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187087

29 September 2017

A brief review of the current breast cancer prevention trials and proposals for future trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187087

29 September 2017

Tamoxifen for the prevention of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187087

29 September 2017

Tamoxifen--the treatment of choice. Why look for alternatives?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187087

29 September 2017

Endogenous hormones and breast cancer risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187087

29 September 2017

Regulation of insulin-like growth factors by antiestrogen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187087

29 September 2017

Nutritional regulation of IGF-I and IGF binding proteins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187087

29 September 2017

Tamoxifen reduces endogenous and UV light-induced oxidative damage to DNA, lipid and protein in vitro and in vivo.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187087

2 June 2018

Alterations in the insulin-like growth factor system during the menstrual cycle in normal women.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187087

2 June 2018

Changes in serum concentrations of growth hormone, insulin, insulin-like growth factor and insulin-like growth factor-binding proteins 1 and 3 and urinary growth hormone excretion during the menstrual cycle.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187087

2 June 2018

William L. McGuire Memorial Lecture. Antiestrogens: mechanisms of action and resistance in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187087

2 June 2018

Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187087

2 June 2018

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187087

2 June 2018

Inhibition of protein kinase C by tamoxifen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187087

2 June 2018

Effect of tamoxifen on serum insulinlike growth factor I levels in stage I breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1187087

2 June 2018

Modulation of endometrial transforming growth factor beta (TGFbeta) by tamoxifen

1 reference

https://pubmed.ncbi.nlm.nih.gov/11577172

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of ornithine decarboxylase gene expression in MCF-7 breast cancer cells by antiestrogens

1 reference

https://pubmed.ncbi.nlm.nih.gov/11577172

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of angiogenesis by antiestrogens

1 reference

https://pubmed.ncbi.nlm.nih.gov/11577172

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of oestrogen status on serum levels of growth hormone-binding protein and insulin-like growth factor-I in non-pregnant and pregnant women

1 reference

https://pubmed.ncbi.nlm.nih.gov/11577172

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma insulin-like growth factor I and its binding proteins 1 and 3 in postmenopausal patients with breast cancer receiving long term tamoxifen

1 reference

https://pubmed.ncbi.nlm.nih.gov/11577172

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11577172

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of treatment with tamoxifen and change in tumor burden on the IGF-system in breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11577172

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating concentrations of insulin-like growth factor I and risk of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11577172

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/MP.54.5.307

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11577172%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11577172%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11577172%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28360503&oldid=1949829818"